Physician profile
Dean A Bauer
NPI 1104845908
$2,746.13
in general payments reported to CMS, 2019-2025
21 companies · $267 in 2025
The $267 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $296 · 2020: $205 · 2021: $630 · 2022: $427 · 2023: $550 · 2024: $371 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,187.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $887.98 | 2019-2025 | Myday Contact Lens, Paragon Crt, Onefit Contact Lens |
| Johnson & Johnson Vision Care, INC. | $477.48 | 2020-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $328.65 | 2022-2025 | Infuse, Miebo, Biotrue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $222.72 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $143.11 | 2019-2023 | |
| Alcon Vision LLC | $128.69 | 2020-2025 | Rocklatan |
| Abb Con-Cise Optical Group LLC | $88.27 | 2019-2021 | |
| Abbvie INC. | $78.74 | 2022-2025 | Durysta |
| Shire North American Group INC | $66.26 | 2019 | |
| Thea Pharma INC. | $61.53 | 2022-2023 | |
| Optovue, INC. | $55.92 | 2019 | |
| Synergeyes, INC. | $54.00 | 2021-2022 | |
| Rxsight INC | $29.74 | 2022-2023 | Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens, Rxsight Light Adjustable Lens (Rxlal) |
| Carl Zeiss Meditec USA, INC. | $19.45 | 2025 | Quatera 700 |
| Tarsus Pharmaceuticals, INC. | $18.66 | 2024 | Xdemvy |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visioneering Technologies, INC. | $15.89 | 2019 | |
| Allergan, INC. | $15.29 | 2021 | |
| Maculogix, INC. | $13.90 | 2021 | |
| New World Medical,INC. | $13.65 | 2020 | |
| Optos, INC. | $13.21 | 2019 | |
| Sight Sciences, INC. | $12.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dean Bauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.